Tag: phase III trial

EU approves AZ’ Forxiga for type I diabetes

by Anna Smith | Mar 26, 2019 | News | 0

The drug is the first oral medicine approved in Europe as an adjunct to insulin for adults with type I diabetes.

Alzheimer’s trial discontinued due to inefficiency

by Anna Smith | Mar 25, 2019 | News | 0

Two global Phase III trials of the Alzheimer’s drug aducanumab have been discontinued, after the drug failed to hit efficacy targets.

Isatuximab shows positive results in Phase III trial for multiple myeloma

by Anna Smith | Feb 5, 2019 | News | 0

A Phase III trial of Sanofi’s isatuximab’s has proven successful, showing that the drug achieved the primary endpoint of prolonging progression free survival in patients with relapsed/refractory multiple myeloma.

Green light for Amryt’s epidermolysis bullosa study

by Anna Smith | Jan 7, 2019 | News | 0

An Independent Data Monitoring Committee (IDCM) has recommended that Amryt’s pivotal Phase III EASE trial for AP101 – a potential treatment for Epidermolysis Bullosa (EB) – should continue, raising hopes for a new therapy for the condition.